Related Experiment Video
Updated: May 20, 2025

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
MEIS1::NCOA1 Primitive Spindle Cell Sarcoma of the Kidney : Report of 7 Cases of a Distinctive Clinicopathologic
Pedram Argani1, Sintawat Wangsiricharoen2, Maria Tretiakova3
1Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract:
Primitive sarcomas harboring the MEIS1::NCOA2 gene fusion were originally described in the kidney in 2018, and subsequently reported in other organs. These variably cellular neoplasms feature monomorphic primitive plump spindle cells forming nodules and whorls in addition to nondescript fascicular, solid, and storiform patterns. They lack skeletal muscle differentiation in contrast to the primarily intraosseous rhabdomyosarcomas that harbor the same gene fusion. We describe 7 new primary primitive renal sarcomas with MEIS1::NCOA1 gene fusions. Although their morphology overlaps with that described in MEIS1::NCOA2 renal sarcoma, 3 of the 7 cases contained adipose tissue. The majority had intimately admixed entrapped cystic epithelial elements and demonstrated patchy immunoreactivity for estrogen receptor and nuclear labeling for WT1 protein, leading to the differential diagnosis of malignant mixed epithelial stromal tumor (MEST) in 4 cases and metanephric stromal tumor in one. The neoplasms demonstrate a broad spectrum of clinicopathologic features ranging from a bland low-grade neoplasm that metastasized 9 years after diagnosis to a high-grade sarcoma with multiple recurrences, ultimately leading to patient death in under 1 year. In summary, MEIS1::NCOA1 primitive sarcomas overlap with the previously described MEIS1::NCOA2 primitive renal sarcomas and represent a distinctive renal neoplasm that can be mistaken for malignant MEST. Grade ranges from low to high but even low-grade neoplasms require long-term clinical follow-up.
Insights
New primitive renal sarcomas with MEIS1::NCOA1 gene fusions were identified. These tumors share features with MEIS1::NCOA2 sarcomas but can be mistaken for other kidney cancers.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Primitive sarcomas with MEIS1::NCOA2 gene fusions were first identified in the kidney in 2018.
- These neoplasms exhibit variable cellularity and specific growth patterns, lacking skeletal muscle differentiation.
Purpose of the Study:
- To describe 7 new cases of primary primitive renal sarcomas with MEIS1::NCOA1 gene fusions.
- To compare their morphology and clinicopathologic features with previously described MEIS1::NCOA2 renal sarcomas.
Main Methods:
- Morphological and immunohistochemical analysis of 7 primary renal sarcomas.
- Genetic analysis to identify MEIS1::NCOA1 gene fusions.
Main Results:
- The 7 new sarcomas showed overlapping morphology with MEIS1::NCOA2 renal sarcomas, with 3 cases containing adipose tissue.
- Four cases were initially misdiagnosed as malignant mixed epithelial stromal tumor (MEST) due to admixed epithelial elements and patchy WT1/estrogen receptor expression.
- Clinicopathologic features ranged from low-grade to high-grade, with one low-grade case metastasizing after 9 years and a high-grade case leading to death within a year.
Conclusions:
- MEIS1::NCOA1 primitive renal sarcomas are a distinct entity that can be mistaken for MEST.
- These neoplasms present a spectrum of behavior, necessitating long-term clinical follow-up even for low-grade tumors.
More Related Videos
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024